Gonzaga, Ariane Myrl A.

HRN: 29-92-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2026
CEFUROXIME 750MG (VIAL)
07/14/2026
07/21/2026
IV
750mg
Q8h
Avulsed Wound Right Arm
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: